1. Early Experience of TACE Combined with Atezolizumab plus Bevacizumab for Patients with Intermediate-Stage Hepatocellular Carcinoma beyond Up-to-Seven Criteria: A Multicenter, Single-Arm Study. (15th April 2023) Authors: Wang, Kang; Zhu, Hongfei; Yu, Hongming; Cheng, Yuqiang; Xiang, Yanjun; Cheng, Zhangjun; Li, Yang; Li, Tao; Wang, Dongxu; Zhu, Zhenyu; Cheng, Shuqun Other Names: Wu Haigang Academic Editor. Journal: Journal of oncology Issue: Volume 2023(2023) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗